Scholar Rock Holding Corp (SRRK)
9.48
+0.09
(+0.96%)
USD |
NASDAQ |
Jun 03, 16:00
9.475
0.00 (0.00%)
After-Hours: 20:00
Scholar Rock Cash and Short Term Investments (Quarterly): 238.43M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 238.43M |
| December 31, 2023 | 279.94M |
| September 30, 2023 | 218.64M |
| June 30, 2023 | 248.73M |
| March 31, 2023 | 275.28M |
| December 31, 2022 | 315.36M |
| September 30, 2022 | 343.66M |
| June 30, 2022 | 370.69M |
| March 31, 2022 | 210.21M |
| December 31, 2021 | 252.99M |
| September 30, 2021 | 246.44M |
| June 30, 2021 | 282.22M |
| March 31, 2021 | 314.69M |
| Date | Value |
|---|---|
| December 31, 2020 | 341.03M |
| September 30, 2020 | 116.26M |
| June 30, 2020 | 141.18M |
| March 31, 2020 | 160.65M |
| December 31, 2019 | 157.45M |
| September 30, 2019 | 176.08M |
| June 30, 2019 | 185.13M |
| March 31, 2019 | 159.67M |
| December 31, 2018 | 175.64M |
| September 30, 2018 | 103.99M |
| June 30, 2018 | 115.06M |
| March 31, 2018 | 47.76M |
| December 31, 2017 | 57.96M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
116.26M
Minimum
Sep 2020
370.69M
Maximum
Jun 2022
243.75M
Average
247.58M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Amgen Inc | 9.708B |
| Eli Lilly and Co | 2.586B |
| Ocular Therapeutix Inc | 482.89M |
| Alpine Immune Sciences Inc (DELISTED) | 305.66M |
| X4 Pharmaceuticals Inc | 80.87M |